Biological Effects of Cerium Dioxide (CeO2) Nanoparticles in Health and Disease
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (30 June 2019) | Viewed by 14312
Special Issue Editor
Interests: cerium oxide nano particles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The initial studies of the biological effects of cerium dioxide first described nearly 20 years ago stemmed directly from the success of this nanomaterial in industrial applications as a redox catalyst. The observation that nanoceria could reduce oxidative injury in both in vitro and in vivo models launched a myriad of studies examining the therapeutic potential of these nanoparticles in a variety of organ systems and disease states including cardiac myopathy, stroke, macular degeneration, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, traumatic brain injury, sepsis, retinal degeneration, wound healing, diabetes and liver failure. While the first wave of publications were focused on the ability of nanoceria to reduce oxidative damage, more recent studies have provided evidence that the biological actions of ceria may be far broader than previously envisioned. Over the past decade there is burgeoning evidence of a potential role of CeNPs in the treatment of a number of neoplasms. Data from the field of oncology have shown that CeNPs may regulate a variety of biological processes including gene expression, angiogenesis, cell cycling and key regulators in programmed cell death in several forms of cancer.
We would encourage investigators to consider submitting original manuscripts to this Special Issue of Biomolecules dedicated to the biology of nanoceria. Particular emphasis will be on submissions using in vitro or in vivo approaches to examine the cellular, tissue or organismal effects of ceria nanoparticles on fundamental biological processes either in health or disease.
Prof. Joseph Erlichman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Cerium Dioxide
- Nanoceria
